Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 5/20 | 0.37 |
| ▸ | CNR2 | P34972 | 5/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | THRA | P10827 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29914201 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL29914159 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL29914196 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL29914178 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL1953362 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL1951903 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL1955419 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL1952588 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL1954266 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG | |
| SCHEMBL29914195 | 1.00 | TSHR (0.48) | TSHRCNR1CNR2PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9714215-B2 | Method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-07-25 | — | — | US | disclosed |
| US-20160052874-A1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-02-25 | — | — | US | disclosed |
| US-8957241-B2 | Method for producing carbonyl compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-20130178645-A1 | Method for Producing Carbonyl Compund | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-07-11 | — | — | US | disclosed |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | CPS1, ALKBH3, RCC1 | TSHR 4686/4885CNR1 400/4885CNR2 210/4885 |
| US-20130178645-A1 | Method for Producing Carbonyl Compund | CA6, CPS1, C9 | TSHR 4304/4885CNR1 1794/4885CNR2 1956/4885 |
| US-20160052874-A1 | METHOD FOR PRODUCING ISOCYANATE | CPS1, ALKBH3, IDH3A | TSHR 4410/4885CNR1 1777/4885CNR2 1205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.